CREST-2 Trials (2025) Medical Management vs Revascularization for Asymptomatic Carotid StenosisTwo parallel, observer-blinded randomized clinical trials (Stenting + CEA) Objective:To determine whether adding carotid revascularization (stenting or endarterectomy) to intensive medical management provides additional benefit over medical therapy alone in … Read More
stroke
VESALIUS-CV Trial: Evolocumab in Patients without MI or Stroke
VESALIUS-CV Trial (2025) Evolocumab in Patients without a Previous Myocardial Infarction or StrokeInternational, double-blind, randomized, placebo-controlled trial Objective:Among patients with atherosclerosis or diabetes but no prior MI or stroke, does long-term PCSK9 inhibition with evolocumab reduce the risk of first … Read More
ASSET-IT Trial: Early Tirofiban Infusion in Stroke
The 2025 ASSET-IT trial investigated whether early intravenous infusion of tirofiban, an antiplatelet agent, following intravenous thrombolysis could improve outcomes in patients with acute noncardioembolic ischemic stroke who are not eligible for thrombectomy. This phase 3, double-blind, randomized, placebo-controlled study … Read More
CHANCE-3 Trial: Colchicine in Acute Stroke
Colchicine for Stroke Prevention (CHANCE-3 Trial) 📍 Study Type: Randomized, placebo-controlled trial🏥 Setting: 244 hospitals in China👥 Participants: 8,343 patients (age ≥40) with minor/moderate ischemic stroke or TIA & hs-CRP ≥2 mg/L Intervention vs. Control 💊 Colchicine Group (n=4,176)• 0.5 … Read More
POST-TNK Trial: Intra-Arterial Tenecteplase in Acute Stroke
Visual Summary of POST-TNK Trial Objective:To evaluate the efficacy and safety of intra-arterial tenecteplase in patients with large vessel occlusion stroke achieving near-complete to complete reperfusion after EVT. Design & Participants: Interventions:Patients were randomized into two groups: Primary Outcome:Freedom from … Read More
ATTENTION Trial: Endovascular Treatment for Acute Basilar-Artery Occlusion
Published in the New England Journal of Medicine (2022), the ATTENTION Trial is a landmark study exploring the efficacy and safety of endovascular treatment (EVT) for patients with acute basilar artery occlusion (BAO). Here’s an in-depth look at the findings … Read More
ATTEST-2 Trial: Tenecteplase vs. Alteplase for Stroke
ATTEST-2 Trial — Comparing Tenecteplase and Alteplase for Acute Stroke Management Introduction In recent years, the quest for optimal treatments for acute ischemic stroke has intensified, with the goal of improving outcomes and accessibility of care. The ATTEST-2 trial, published … Read More
ARCADIA Trial: Apixaban After Cryptogenic Stroke
The ARCADIA trial, published in JAMA in 2024, compared the efficacy of apixaban versus aspirin in preventing recurrent strokes in patients with cryptogenic stroke and atrial cardiopathy. Key Findings: Conclusion: In patients with cryptogenic stroke and evidence of atrial cardiopathy … Read More
INTERACT4 Trial: Ambulance care for Stroke
INTERACT4 Trial Intensive Ambulance-Delivered Blood-Pressure Reduction in Hyperacute Stroke A multicentre, randomized, open-label trial Objective:To determine the effect of prehospital treatment of elevated systolic blood pressure (SBP) in patients with recent onset of symptoms concerning for acute stroke. 2404 Patients … Read More
ARTESIA Trial: Apixaban for Subclinical AFib
ARTESIA Trial Summary The ARTESIA trial, which stands for “Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation,” was a landmark study aimed at comparing the efficacy and safety of apixaban versus aspirin in patients with subclinical atrial fibrillation (AF). The … Read More